Return On Equity of Seres Therapeutics, Inc. from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Seres Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • Seres Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 15%, a 75% decline year-over-year.
  • Seres Therapeutics, Inc. annual Return On Equity for 2024 was -0.5%, a 100% decline from 2023.
  • Seres Therapeutics, Inc. annual Return On Equity for 2023 was 534%.
  • Seres Therapeutics, Inc. annual Return On Equity for 2022 was -549%, a 1055% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Seres Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 15% -45% -75% 01 Jul 2025 30 Sep 2025
Q2 2025 284% -30% -9.5% 01 Apr 2025 30 Jun 2025
Q1 2025 26673% +26333% +7731% 01 Jan 2025 31 Mar 2025
Q4 2024 -0.5% -534% -100% 01 Oct 2024 31 Dec 2024
Q3 2024 61% -1849% -97% 01 Jul 2024 30 Sep 2024
Q2 2024 314% +1469% 01 Apr 2024 30 Jun 2024
Q1 2024 341% +2318% 01 Jan 2024 31 Mar 2024
Q4 2023 534% +1082% 01 Oct 2023 31 Dec 2023
Q3 2023 1909% +2215% 01 Jul 2023 30 Sep 2023
Q2 2023 -1155% -1055% -1052% 01 Apr 2023 30 Jun 2023
Q1 2023 -1977% -1906% -2688% 01 Jan 2023 31 Mar 2023
Q4 2022 -549% -501% -1055% 01 Oct 2022 31 Dec 2022
Q3 2022 -305% -283% -1243% 01 Jul 2022 30 Sep 2022
Q2 2022 -100% -13% -15% 01 Apr 2022 30 Jun 2022
Q1 2022 -71% +24% +25% 01 Jan 2022 31 Mar 2022
Q4 2021 -48% +104% +69% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% +2845% +99% 01 Jul 2021 30 Sep 2021
Q2 2021 -87% -233% -160% 01 Apr 2021 30 Jun 2021
Q1 2021 -95% -259% -158% 01 Jan 2021 31 Mar 2021
Q4 2020 -151% -318% -191% 01 Oct 2020 31 Dec 2020
Q3 2020 -2868% -3041% -1756% 01 Jul 2020 30 Sep 2020
Q2 2020 146% -42% -23% 01 Apr 2020 30 Jun 2020
Q1 2020 164% -71% -30% 01 Jan 2020 31 Mar 2020
Q4 2019 167% -317% -65% 01 Oct 2019 31 Dec 2019
Q3 2019 173% +1757% 01 Jul 2019 30 Sep 2019
Q2 2019 188% +444% 01 Apr 2019 30 Jun 2019
Q1 2019 236% +386% 01 Jan 2019 31 Mar 2019
Q4 2018 484% +587% 01 Oct 2018 31 Dec 2018
Q3 2018 -1584% -1502% -1830% 01 Jul 2018 30 Sep 2018
Q2 2018 -256% -176% -219% 01 Apr 2018 30 Jun 2018
Q1 2018 -150% -82% -118% 01 Jan 2018 31 Mar 2018
Q4 2017 -103% -47% -82% 01 Oct 2017 31 Dec 2017
Q3 2017 -82% -34% -71% 01 Jul 2017 30 Sep 2017
Q2 2017 -80% -38% -92% 01 Apr 2017 30 Jun 2017
Q1 2017 -69% -32% -84% 01 Jan 2017 31 Mar 2017
Q4 2016 -57% 01 Oct 2016 31 Dec 2016
Q3 2016 -48% 01 Jul 2016 30 Sep 2016
Q2 2016 -42% 01 Apr 2016 30 Jun 2016
Q1 2016 -37% 01 Jan 2016 31 Mar 2016

Seres Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -0.5% -534% -100% 01 Jan 2024 31 Dec 2024
2023 534% +1082% 01 Jan 2023 31 Dec 2023
2022 -549% -501% -1055% 01 Jan 2022 31 Dec 2022
2021 -48% +104% +69% 01 Jan 2021 31 Dec 2021
2020 -151% -318% -191% 01 Jan 2020 31 Dec 2020
2019 167% -317% -65% 01 Jan 2019 31 Dec 2019
2018 484% +587% 01 Jan 2018 31 Dec 2018
2017 -103% -47% -82% 01 Jan 2017 31 Dec 2017
2016 -57% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.